Illumina stock forecast.

People use statistics daily for weather forecasts, predicting disease, preparing for emergencies, medical research, political campaigns, tracking sales, genetics, insurance, the stock market and quality testing.Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2022. February 7, 2023. Revenue of $1.08 billion for Q4 2022, down 10% from Q4 2021, and down 7% on a constant currency basis. Revenue of $4.58 billion for fiscal year 2022, up 1% from fiscal year 2021, and up 3% on a constant currency basis.Dec 1, 2023 · Illumina Inc Stock Forecast and Price Target. According to fourteen experts, who recently provided their 2023 price targets for Illumina Inc, the average price target is $140.00, with a high estimate of $260.00 and a low estimate of $50.00. That is a potential upside of approximately 37.32% from the last closing price of $101.95 on November, 2023. Oct 16, 2023 · In the last 3 months, 14 analysts have offered 12-month price targets for Illumina. The company has an average price target of $203.64 with a high of $285.00 and a low of $100.00. Below is a ...

GH Stock 12 Months Forecast. $46.93. (101.59% Upside) Based on 14 Wall Street analysts offering 12 month price targets for Guardant Health in the last 3 months. The average price target is $46.93 with a high forecast of $64.00 and a low forecast of $27.00. The average price target represents a 101.59% change from the last price of $23.28.Future criteria checks 3/6. Illumina is forecast to grow earnings and revenue by 80.3% and 7.6% per annum respectively. EPS is expected to grow by 81.3% …

CEO Approval. Business Outlook. Pros. Good benefits, mostly good work/life balance (in software, at least), ESPP is nice (though the stock has been terrible). Cons. A coworker was verbally abused by our manager. After the coworker brought the case to HR (as per illumina's own training), HR squelched the case and exonerated the …

Bionano Genomics ( NASDAQ:BNGO ) $552.3 million. Pioneer in optical genome mapping technology. 1. Illumina. Since its 1998 founding, Illumina has become an industry leader with more than 90% of ...Source: vxhal/ShutterStock.com. Illumina (NASDAQ: ILMN) stock is down nearly 10% today after a tumultuous second quarter earnings call. The California-based gene-sequencing company failed to meet ...Simply Wall St. July 22, 2023 at 7:00 AM · 3 min read. Today we're going to take a look at the well-established Illumina, Inc. ( NASDAQ:ILMN ). The company's stock received a lot of attention ...Evercorse analyst Vijay Kumar called the results a "incremental positive," adding that Illumina (NASDAQ:ILMN) stock should return to the $200-$210 range. With the proxy battle now behind it, Kumar ...HUM Stock 12 Months Forecast. $588.80. (18.91% Upside) Based on 15 Wall Street analysts offering 12 month price targets for Humana in the last 3 months. The average price target is $588.80 with a high forecast of $640.00 and a low forecast of $550.00. The average price target represents a 18.91% change from the last price of $495.18.

See the latest Illumina Inc stock price (ILMN:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

ILMN stock analysts forecast earnings of $1.37 per share and $4.94 billion in sales this year. On the stock market today , ILMN stock tumbled 3.5% to end the regular session at 210.96.

Illumina shareholders re-elect eight of nine Illumina directors. SAN DIEGO, May 25, 2023 /PRNewswire/ -- Illumina (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that based on the preliminary results of its 2023 Annual Meeting, Illumina shareholders have voted to elect eight of …People use statistics daily for weather forecasts, predicting disease, preparing for emergencies, medical research, political campaigns, tracking sales, genetics, insurance, the stock market and quality testing.Delivering Value to Investors. A global leader in DNA sequencing and array-based technologies, Illumina is fueling advancements in life sciences, oncology, …Illumina’s stock on track for lowest close in 10 years after cutting guidance Nov. 10, 2023 at 10:16 a.m. ET by Ciara Linnane Biotech and Pharma Illumina Stock Is the Worst Performer in the S&P 500. Aug 10, 2023 · The earnings forecast is 55 cents lower, at the midpoint, than Illumina's previous outlook. ... Still, Mikson remained bullish on Illumina stock. On the stock market today, ILMN stock rose 0.3% ... Illumina Stock Forecast 12-06-2023. Forecast target price for 12-06-2023: $ 100.50. Positive dynamics for Illumina shares will prevail with possible volatility of 1.073%. Pessimistic target level: 100.05. Optimistic target level: 101.14.8 Jul 2023 ... By evaluating the price data of the ILMN Share, it can be said that it is presently in a downtrend. The profit margin of the stock is -100.88%.

Bionano Genomics ( NASDAQ:BNGO ) $552.3 million. Pioneer in optical genome mapping technology. 1. Illumina. Since its 1998 founding, Illumina has become an industry leader with more than 90% of ...For ILLUMINA INC stock forecast for 2028 (5 year), 12 predictions are offered for each month of 2028 with average ILLUMINA INC stock forecast of $117.71, a high forecast of $140.93, and a low forecast of $87.66. The average ILLUMINA INC stock forecast 2028 represents a 17.51% increase from the last price of $100.169998168945.Oct. 16, 2023, 03:00 PM Over the past 3 months, 14 analysts have published their opinion on Illumina (NASDAQ:ILMN) stock. These analysts are typically employed by large Wall …Get a real-time Illumina, Inc. (ILMN) stock price quote with breaking news, financials, statistics, charts and more. ... The 12-month stock price forecast is $200.33 ...Analyzing the anticipated performance of Illumina, the ceiling value that the stock is expected to reach in 2024 stands at a promising $159.52.Indicating a bullish trend, an upside potential of 22.33% signals profitable prospects, with an average monthly return of 1.6%, beckoning investors to consider amplifying their portfolios.Buy Illumina Stock. Illumina Inc (ILMN) is a publicly traded diagnostics & research business based in the US. It opened the day at $95.99 after a previous close of $95.2. During the day the price has varied from a low of $92.69 to a high of $96.2. The latest price was $94.32 (25 minute delay). Illumina is listed on the NASDAQ and employs 11,500 ...

Jul 10, 2023 · July 10, 2023 — 12:15 am EDT. Illumina stock (NASDAQ: ILMN) currently trades at $187 per share, roughly 51% below its level in March 2021, and it can see solid returns over time. ILMN saw its ... Illumina (NASDAQ:ILMN) is a biotech company that develops and sells life science tools and integrated systems for genomic research. The stock has a consensus …

Illumina ( NASDAQ: ILMN) closed down 6% on Tuesday after its 2023 outlook came in below expectations. The company projects 2023 revenue of $4.9B–5.03B this year compared to consensus of $5.05B ...Illumina, Inc. Common Stock (ILMN) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Part of deSouza's pay bump is a special grant of stock options worth $12.5 million, which Illumina called a "meaningful retention incentive in a highly competitive talent environment."Nov 29, 2023 · The Illumina stock price gained 1.87% on the last trading day (Wednesday, 22nd Nov 2023), rising from $95.97 to $97.76. During the last trading day the stock fluctuated 2.00% from a day low at $96.91 to a day high of $98.85. The price has fallen in 6 of the last 10 days and is down by -11.69% for this period. Volume fell on the last day by -895 ... The average Illumina stock price prediction forecasts a potential upside of 58.12% from the current ILMN share price of $109.79. What is ILMN's forecast return on equity (ROE) for 2023-2025? ( NASDAQ : ILMN ) forecast ROE is N/A , which is considered weak . 7 Jul 2023 ... Illumina stock (NASDAQ NDAQ +0.2% : ILMN) currently trades at $187 per share, roughly 51% below its level in March 2021, and it can see ...

Illumina Stock (NASDAQ:ILMN), Analyst Ratings, Price Targets, Predictions. Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 ...

June 14, 2023 at 11:22 AM · 5 min read. Illumina, Inc. ILMN is well poised for growth in the coming quarters, owing to solid long-term growth potential in the oncology space. The company ended ...

Dec 1, 2023 · Illumina (NASDAQ:ILMN) is a biotech company that develops and sells life science tools and integrated systems for genomic research. The stock has a consensus rating of Hold and a price target of $217.47, up 99.1% from its current price of $109.22. See the latest news, analysis, and earnings reports for Illumina on MarketBeat. Illumina, Inc. Common Stock is estimated to report earnings on 08/10/2023. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor ...Source: vxhal/ShutterStock.com. Illumina (NASDAQ: ILMN) stock is down nearly 10% today after a tumultuous second quarter earnings call. The California-based gene-sequencing company failed to meet ...The average Illumina stock price prediction forecasts a potential upside of 58.12% from the current ILMN share price of $109.79. What is ILMN's forecast return on equity (ROE) for 2023-2025? ( NASDAQ : ILMN ) forecast ROE is N/A , which is considered weak . In this article, we discuss 12 of the best medical device stocks to buy now. If you want to skip our detailed healthcare and medical technology industry discussion, head directly to the 5 Best ...Illumina sequencing and array technologies fuel advancements in life science research, translational and consumer genomics, and molecular diagnostics.See the latest Illumina Inc stock price (ILMN:XNAS), related news, valuation, dividends and more to help you make your investing decisions.Stock Price Forecast. According to 15 stock analysts, the average 12-month stock price forecast for Illumina stock is $200.33, which predicts an increase of 82.47%. The lowest target is $100 and the highest is $334. On average, analysts rate Illumina stock as a hold.* Price Target & Stock Forecast ; Full Company Report ... Illumina, Inc. has a VGM Score of F (this is a weighted average of the individual Style Scores which allow you to focus on the stocks that ...Nov 27. Nov 2014 2016 2018 2020 2022 75 100 125 150 175 0 2.5M 5M 7.5M 10M. XNAS:ILMN,NASDAQ:ILMN historical stock data. Stock Date. Stock Price. November 30, 2023. $101.95. November 29, 2023. $101.57.On today's stock market, Illumina stock surged 2.5% to close at 201.02. Grail's Hang On Illumina Stock The battle to acquire Grail has been an albatross draped over Illumina.

Illumina's stock (ILMN) rose in the intraday levels while correcting the main downward trend, as the stock retests the resistance of the secondary trend line in the short term, coinciding with touching the resistance of the 50-day SMA, doubling negative pressures, with negative signals from the RSI despite reaching overbought levels, hinting …In the last 3 months, 14 analysts have offered 12-month price targets for Illumina. The company has an average price target of $203.64 with a high of $285.00 and a low of $100.00. Below is a ...0.00%. $130.57B. PACB | Complete Pacific Biosciences of California Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Instagram:https://instagram. stock option value calculatordental coverage hawaiiapples earnings reporthealthcare reit etf Illumina. Market Cap. Today's Change. (-0.92%) -$0.88. Current Price. $94.32. You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services ...Illumina (NASDAQ:ILMN) is a biotech company that develops and sells life science tools and integrated systems for genomic research. The stock has a consensus … psychology of money morgan houseleusoh Aug 10, 2023 · The earnings forecast is 55 cents lower, at the midpoint, than Illumina's previous outlook. ... Still, Mikson remained bullish on Illumina stock. On the stock market today, ILMN stock rose 0.3% ... benzinga pre market ILMN Earnings Date and Information. Illumina last released its quarterly earnings results on November 9th, 2023. The life sciences company reported $0.33 EPS for the quarter, beating analysts' consensus estimates of $0.13 by $0.20. The company earned $1.12 billion during the quarter, compared to analysts' expectations of $1.13 billion.The base stock consideration was subject to a collar, where the number of shares issued at closing varied in the event the 20-trading-day volume weighted average price of Illumina stock as of 10 trading days prior to closing is between $295 and $399 but was fixed at 11.3 million shares if such volume weighted average share price is above …The stock price has decreased by -51.30% in the last 52 weeks. The beta is 1.16, so Illumina's price volatility has been higher than the market average. Beta (1Y)